Dysregulation of the PI3K/Akt/mTOR pathway is often the result of loss or inactivation of tumor suppressors, mutation or amplification of PI3K, as well as activation of RTKs or oncoproteins upstream of PI3K (Figure 3) [102,103]. This evidence concerns the gene PIK3CA and neoplasm.